Integrated research for pathogenesis and epidemiology of chronic obstructive pulmonary disease

慢性阻塞性肺疾病发病机制和流行病学的综合研究

基本信息

  • 批准号:
    17390239
  • 负责人:
  • 金额:
    $ 9.92万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2005
  • 资助国家:
    日本
  • 起止时间:
    2005 至 2006
  • 项目状态:
    已结题

项目摘要

Epidemiological evidence suggests that cigarette smoking and aging are the two major risk factors for the development of chronic obstructive pulmonary disease (COPD). The molecular mechanism is poorly understood, in which the pathophysiology of COPD is involved. Respiratory tract is the major interface to the environment and the lung epithelium and alveolar macrophages are the first line of defense against cigarette smoke. We found that cumulative effects of aging and long-term smoking differently affected the accumulation of glutathione disulfide, an oxidized form of glutathione associated with excessive carbonyl proteins in BAL fluid, which might lead to the impaired antioxidant barrier system in the extracellular milieu in alveolar space. The lungs are anatomically complex organs. We first applied laser capture microdissection (LCM) techniques to analyze cell-specific gene expression in the smoking lungs. This study provides the molecular information of bronchiolar epithelium, macrophages, and alveolar septae in the pathogenesis of COPD. The combination of LCM with nucleotide arrays offers exciting discovery of the molecular responses of different lung cells to smoke exposure. We especially focus on the groups of genes controlling the defense mechanism, regulating the inflammation, and contributing to the maintenance of lung structure, which is related to cell apoptosis and repair. The cell-specific gene expression profile in COPD patients as well as in smoking mice could open the possibilities for the development of new therapeutic strategies, considering targeted site and the delivery of drugs.
流行病学证据表明,吸烟和衰老是慢性阻塞性肺疾病(COPD)发生的两大危险因素。其分子机制尚不清楚,其中涉及COPD的病理生理学。呼吸道是环境的主要界面,肺上皮和肺泡巨噬细胞是抵御香烟烟雾的第一道防线。我们发现,衰老和长期吸烟的累积效应不同地影响了BAL液中谷胱甘肽二硫化物的积累,谷胱甘肽二硫化物是谷胱甘肽的一种氧化形式,与过量的羰基蛋白有关,这可能导致肺泡腔细胞外环境的抗氧化屏障系统受损。肺是解剖学上复杂的器官。我们首次应用激光捕获显微解剖(LCM)技术来分析吸烟肺中细胞特异性基因的表达。本研究提供了细支气管上皮、巨噬细胞和肺泡间隔在COPD发病机制中的分子信息。LCM与核苷酸阵列的结合提供了不同肺细胞对烟雾暴露的分子反应的令人兴奋的发现。我们特别关注控制防御机制、调节炎症和有助于维持肺结构的基因组,这些基因与细胞凋亡和修复有关。COPD患者和吸烟小鼠的细胞特异性基因表达谱可能为开发新的治疗策略打开可能性,考虑到靶点和药物传递。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Long term smoking with age builds up excessive oxidative stress in bronchoalveolar lavage fluid
  • DOI:
    10.1136/thx.2005.049148
  • 发表时间:
    2006-06-01
  • 期刊:
  • 影响因子:
    10
  • 作者:
    Nagai, K.;Betsuyaku, T.;Nishimura, M.
  • 通讯作者:
    Nishimura, M.
Extracellular matrix metalloproteinase inducer in interstitial pneumonias
  • DOI:
    10.1016/j.humpath.2006.03.006
  • 发表时间:
    2006-08-01
  • 期刊:
  • 影响因子:
    3.3
  • 作者:
    Odajima, Nao;Betsuyaku, Tomoko;Nishimura, Masaharu
  • 通讯作者:
    Nishimura, Masaharu
Decrease of vascular endothelial growth factor in macrophages from long-term smokers
  • DOI:
    10.1183/09031936.05.00110504
  • 发表时间:
    2005-04-01
  • 期刊:
  • 影响因子:
    24.3
  • 作者:
    Nagal, K;Betsuyaku, T;Nishimura, M
  • 通讯作者:
    Nishimura, M
Role of macrophage migration inhibitory factor in ovalbumin-induced airway inflammation in rats
  • DOI:
    10.1183/09031936.06.00107004
  • 发表时间:
    2006-04-01
  • 期刊:
  • 影响因子:
    24.3
  • 作者:
    Kobayashi, M;Nasuhara, Y;Nishimura, M
  • 通讯作者:
    Nishimura, M
Airflow limitation and airway dimensions in chronic obstructive pulmonary disease
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NISHIMURA Masaharu其他文献

NISHIMURA Masaharu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NISHIMURA Masaharu', 18)}}的其他基金

Role of apoptosis inhibitor of macrophage (AIM) in the pathogenesis of intractable lung diseases
巨噬细胞凋亡抑制剂(AIM)在难治性肺部疾病发病机制中的作用
  • 批准号:
    25670398
  • 财政年份:
    2013
  • 资助金额:
    $ 9.92万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Basic Research on Active Noise Control for Moving Error Points by Multi-channel Wave Synthesis Method
多通道波合成法对移动误差点有源噪声控制的基础研究
  • 批准号:
    22560223
  • 财政年份:
    2010
  • 资助金额:
    $ 9.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding the pathogenesis of severe airway diseases by large cohort studies
通过大型队列研究了解严重气道疾病的发病机制
  • 批准号:
    21390253
  • 财政年份:
    2009
  • 资助金额:
    $ 9.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Dehydroxymethylepoxyquinomicin(DHMEQ), a novel NF-kappaB inhibitor, inhibits allergic inflammation and airway remodeling in murine models of asthma
脱羟甲基环氧喹诺星 (DHMEQ) 是一种新型 NF-kappaB 抑制剂,可抑制哮喘小鼠模型中的过敏性炎症和气道重塑
  • 批准号:
    21659206
  • 财政年份:
    2009
  • 资助金额:
    $ 9.92万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Basic Research on Active Acoustic Shielding
主动声屏蔽的基础研究
  • 批准号:
    19560232
  • 财政年份:
    2007
  • 资助金额:
    $ 9.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
New challenges to chronic airway diseases-pathogenesis, diagnosis and treatment-
慢性气道疾病的新挑战-发病机制、诊断与治疗-
  • 批准号:
    19390221
  • 财政年份:
    2007
  • 资助金额:
    $ 9.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Smoking susceptibility and pathogenesis of pulmonary emphysema
吸烟易感性与肺气肿发病机制
  • 批准号:
    13470125
  • 财政年份:
    2001
  • 资助金额:
    $ 9.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
ROLE OF BRAIN INTERSTITIAL ADENOSINE IN HYPOXIC VENTILATORY DEPRESSION
脑间质腺苷在缺氧通气抑制中的作用
  • 批准号:
    04670451
  • 财政年份:
    1992
  • 资助金额:
    $ 9.92万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Role of Endogenous Adenosine in Hypoxic Ventilatory Depression
内源性腺苷在缺氧通气抑制中的作用
  • 批准号:
    02670333
  • 财政年份:
    1990
  • 资助金额:
    $ 9.92万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

The role of PUMA in the progression of cigarette smoking-induced COPD
PUMA 在吸烟引起的 COPD 进展中的作用
  • 批准号:
    10930186
  • 财政年份:
    2023
  • 资助金额:
    $ 9.92万
  • 项目类别:
Defining a gene expression signature of airway disease, COPD exacerbations, and response to treatment
定义气道疾病、COPD 恶化和治疗反应的基因表达特征
  • 批准号:
    10733573
  • 财政年份:
    2023
  • 资助金额:
    $ 9.92万
  • 项目类别:
Alveolar Macrophage Iron Overload in COPD Pathogenesis
肺泡巨噬细胞铁过载在慢性阻塞性肺病发病机制中的作用
  • 批准号:
    10740293
  • 财政年份:
    2023
  • 资助金额:
    $ 9.92万
  • 项目类别:
Sex chromosome gene regulatory networks and COPD
性染色体基因调控网络与慢性阻塞性肺病
  • 批准号:
    10570379
  • 财政年份:
    2023
  • 资助金额:
    $ 9.92万
  • 项目类别:
Aberrant Micro-managing of the Airway Epithelial Transcriptome in HIV-associated COPD
HIV 相关 COPD 气道上皮转录组的异常微观管理
  • 批准号:
    10700300
  • 财政年份:
    2023
  • 资助金额:
    $ 9.92万
  • 项目类别:
Developing non-anticoagulant recombinant heparin for treating the COPD Pathogenic Triad
开发非抗凝重组肝素治疗慢性阻塞性肺病致病三联征
  • 批准号:
    10382108
  • 财政年份:
    2022
  • 资助金额:
    $ 9.92万
  • 项目类别:
Implementation and validation of a lung x-ray interferometry imaging system, with applications to COPD, COVID-19 and other lung diseases
肺 X 射线干涉成像系统的实施和验证,应用于 COPD、COVID-19 和其他肺部疾病
  • 批准号:
    10384525
  • 财政年份:
    2022
  • 资助金额:
    $ 9.92万
  • 项目类别:
Resetting the Clock in HIV associated COPD
重置艾滋病毒相关慢性阻塞性肺病的时钟
  • 批准号:
    10672182
  • 财政年份:
    2022
  • 资助金额:
    $ 9.92万
  • 项目类别:
Resetting the Clock in HIV associated COPD
重置艾滋病毒相关慢性阻塞性肺病的时钟
  • 批准号:
    10403032
  • 财政年份:
    2022
  • 资助金额:
    $ 9.92万
  • 项目类别:
Identifying Protein-Protein Network Interactions between COPD Susceptibility Genes
识别 COPD 易感基因之间的蛋白质-蛋白质网络相互作用
  • 批准号:
    10543862
  • 财政年份:
    2021
  • 资助金额:
    $ 9.92万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了